Spiramycin

Kathryn Dzintars, Pharm.D., BCPS, Paul G. Auwaerter, M.D.

INDICATIONS

FDA

  • Spiramycin: not commercially available in the U.S.
    • May be obtained as below (see Adult Dosing)
  • Indicated for treating primary toxoplasmosis in pregnant women to prevent congenital toxoplasmosis (IgM titer needs to be confirmed by Dr. Jack S. Remington Laboratory for Specialty Diagnostics; T: 650-853-4828).

NON-FDA APPROVED USES

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: October 18, 2022